[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@DeepSouthDoctor Avatar @DeepSouthDoctor Keith Abrams

Keith Abrams posts on X about $hrmy, $urgn, $idya, $bcrx the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence finance XXXX%

Social topic influence $hrmy 3.13%, $urgn #3, $idya 3.13%, $bcrx #7, printing 1.56%, money 1.56%, decent 1.56%, $cgon 1.56%, $rgti 1.56%, $atxs XXXX%

Top accounts mentioned or mentioned by @berlinergy @coti36762360 @jeff_walenta @buffalo51766917 @bokhzam @aaronrosenblum5 @sharkbiotech @bo_khzam @65 @ahoriginal @biosntechs @quantumup1 @lblegend33 @miljenkoz @binarypharmer @monacobiotech @andreagtc @avidresearch @richardtip17589 @stevewagsinvest

Top assets mentioned IDEAYA Biosciences, Inc. Common Stock (IDYA) CG Oncology, Inc. Common stock (CGON) Rigetti Computing, Inc. Common Stock (RGTI)

Top Social Posts #


Top posts by engagements in the last XX hours

"$HRMY: Fragile X was to me a "free call" given that it's been a graveyard for drug dev'l. However $HRMY is dirt cheap - EV/prod revenue = XXX for 2025 XXX for 2026. Those values are rarely seen in biotech They're still printing money and have a decent pipeline. Not selling"
X Link @DeepSouthDoctor 2025-09-24T17:57Z 4033 followers, 1684 engagements

"Can anybody tell me why $CGON deserves to have an Enterprise Value 3x $URGN"
X Link @DeepSouthDoctor 2025-10-05T23:54Z 4034 followers, 1542 engagements

"$RGTI: One of these days I might short the stock. Hard to do when it hasn't declined for X consecutive days in a long time"
X Link @DeepSouthDoctor 2025-10-15T13:41Z 4034 followers, 1569 engagements

"$IDYA - I remain a fan of the company after reading yesterday's transcript and reviewing the slide deck. Well capitalized with several "shots on goal" solid science and some impressive early data"
X Link @DeepSouthDoctor 2025-09-09T13:52Z 4030 followers, 1528 engagements

"$BCRX: Read the CC transcript re: $ATXS deal. If Ph3 LAI drug is approvable (data Q127) I like the deal. Company est. 2029 $1B cash balance $1B+ revenue (going to $1.8B in 2033). Early pipeline and possible add'l future BD a potential bonus. All in all it's a solid l-t buy"
X Link @DeepSouthDoctor 2025-10-15T12:50Z 4034 followers, 4483 engagements

"Current holdings in order of size: $RZLT (YE Ph3 data) $TCMD (EV/prod rev 1.0) $IDYA (YE Ph3 data deep pipeline) $URGN (fairly valued) $ABEO (2026 EV/prod rev 1.0) $HRMY ('26 EV/prod rev 1.0) $TECX (EV $X Oct Ph1b data) $BCRX ('26 EV/prod rev 2.0)"
X Link @DeepSouthDoctor 2025-10-06T13:00Z 4034 followers, 3317 engagements